87.21
Merit Medical Systems Inc stock is traded at $87.21, with a volume of 478.99K.
It is up +2.30% in the last 24 hours and up +0.02% over the past month.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
See More
Previous Close:
$85.25
Open:
$85.41
24h Volume:
478.99K
Relative Volume:
0.81
Market Cap:
$5.21B
Revenue:
$1.54B
Net Income/Loss:
$139.34M
P/E Ratio:
37.64
EPS:
2.317
Net Cash Flow:
$217.40M
1W Performance:
+2.16%
1M Performance:
+0.02%
6M Performance:
+27.04%
1Y Performance:
+5.73%
Merit Medical Systems Inc Stock (MMSI) Company Profile
Name
Merit Medical Systems Inc
Sector
Industry
Phone
(801) 253-1600
Address
1600 WEST MERIT PARK WAY, SOUTH JORDAN, UT
Compare MMSI vs ISRG, BDX, RMD, MDLN, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MMSI
Merit Medical Systems Inc
|
87.21 | 5.21B | 1.54B | 139.34M | 217.40M | 2.317 |
|
ISRG
Intuitive Surgical Inc
|
423.96 | 149.78B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
183.75 | 50.05B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
230.05 | 32.35B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
36.26 | 31.81B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
64.11 | 30.99B | 10.63B | 819.00M | 1.59B | 1.6577 |
Merit Medical Systems Inc Stock (MMSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-06-26 | Initiated | BTIG Research | Buy |
| Mar-28-25 | Initiated | JP Morgan | Overweight |
| Dec-11-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jun-28-24 | Initiated | Robert W. Baird | Outperform |
| Apr-11-24 | Initiated | CL King | Buy |
| Feb-07-24 | Initiated | BofA Securities | Neutral |
| Dec-21-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Dec-20-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-05-21 | Upgrade | Needham | Hold → Buy |
| Sep-28-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Feb-25-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Feb-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-12-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Sep-24-19 | Initiated | Oppenheimer | Outperform |
| Sep-10-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Needham | Buy → Hold |
| Jul-26-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-02-18 | Reiterated | Needham | Buy |
| Aug-07-18 | Downgrade | BofA/Merrill | Buy → Underperform |
| Jul-24-18 | Reiterated | Needham | Buy |
| Jun-01-18 | Reiterated | Needham | Buy |
| May-18-18 | Reiterated | SunTrust | Buy |
| Apr-26-18 | Reiterated | Needham | Buy |
| Apr-20-18 | Initiated | Needham | Buy |
| Mar-01-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Aug-28-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-20-17 | Initiated | BofA/Merrill | Buy |
| Jun-20-17 | Initiated | SunTrust | Buy |
| Apr-05-17 | Initiated | Wells Fargo | Outperform |
View All
Merit Medical Systems Inc Stock (MMSI) Latest News
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Zacks Investment Research
Reasons to Retain Hims & Hers Stock in Your Portfolio for Now - Zacks Investment Research
10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research - Zacks Investment Research
Merit Medical Systems, Inc. (MMSI) Stock Forecasts - Yahoo Finance
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - Zacks Investment Research
Q3 2025 Merit Medical Systems Inc Earnings Call Transcript - GuruFocus
Merit Medical Systems Inc Annual Shareholders Meeting Transcript - GuruFocus
Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026 - www.marketscreener.com
Merit Medical Systems, Inc. (MMSI) Stock forecasts - Yahoo Finance UK
HSIC or MMSI: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now - TradingView
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now - TradingView
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now - Zacks Investment Research
Merit Medical Systems (MIL:1MMSI) Cyclically Adjusted PS Ra - GuruFocus
Merit Medical Systems (MIL:1MMSI) Cyclically Adjusted Price-to-FCF : (As of Oct. 06, 2026) - GuruFocus
Merit Medical Systems Inc (MIL:1MMSI) Valuation - GuruFocus
Merit Medical Systems Inc (MIL:1MMSI) Stock HoldersInstitutional & Insider Ownership - GuruFocus
MIL:1MMSI ROE %: 9.40% — 87% Above Median - GuruFocus
Merit Medical Systems Inc (MIL:1MMSI) Stock Price & 30 Year Financial Data - GuruFocus
Merit Medical Systems Inc (MIL:1MMSI) Stock Price, Trades & News - GuruFocus
Merit Medical Systems, Inc. (MMSI) Stock forecasts - Yahoo Finance UK
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex - Zacks Investment Research
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex - Yahoo Finance
Merit Medical Systems (NasdaqGS:MMSI) Stock Forecast & Analyst Predictions - Simply Wall Street
Merit Medical Systems, Inc. (MMSI) Stock Forecasts - Yahoo! Finance Canada
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve - Zacks Investment Research
Merit Medical Systems, Inc. (MMSI) Stock Forecasts - Yahoo Finance
MMSI Reiterated by Needham -- Price Target Maintained at $101 - GuruFocus
Merit Medical Systems, Inc. (MMSI) Stock forecasts - Yahoo Finance UK
Merit Medical Systems, Inc. (MMSI) Stock Forecasts - Yahoo Finance
Merit Medical Systems, Inc. (MMSI) Stock Price, News, Quote & History - ca.finance.yahoo.com
(MMSI) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Merit Medical Systems, Inc. (MMSI) stock price, news, quote and history - Yahoo Finance UK
2 Reasons to Sell MMSI and 1 Stock to Buy Instead - Yahoo Finance
Merit Medical Systems, Inc. (MMSI) Stock Analysis: 18.84% Potential Upside Beckons Investors - DirectorsTalk Interviews
2 Reasons to Sell MMSI and 1 Stock to Buy Instead - The Globe and Mail
MMSI PE Ratio & Valuation, Is MMSI Overvalued - Intellectia AI
The Technical Signals Behind (MMSI) That Institutions Follow - Stock Traders Daily
Motorola Solutions stock gains as buyback boost follows strong Q2 figures - ad-hoc-news.de
Merit Medical at Wells Fargo conference: strategic review deepens By Investing.com - Investing.com South Africa
Motorola Solutions stock gains after strong Q2 guidance raise - ad-hoc-news.de
Merit Medical at Wells Fargo conference: strategic review deepens - Investing.com
Merit Medical at Wells Fargo conference: strategic review deepens By Investing.com - Investing.com Canada
Motorola Solutions stock heads into the open after a 0.7% slip - ad-hoc-news.de
Motorola Solutions (MSI) Expands Share Repurchase Program by $2 Billion, Boosting Total Authorization to $20 Billion - GuruFocus
Motorola Solutions Announces Increase to Share Repurchase Program - 01net
Motorola Solutions boosts buyback program by $2 billion - investing.com
Motorola Solutions boosts buyback program by $2 billion - Investing.com Canada
Motorola Solutions CTO to speak at Piper Sandler conference - Investing.com
Motorola Solutions CTO to speak at Piper Sandler conference By Investing.com - Investing.com Canada
Merit Medical Systems Inc Stock (MMSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Merit Medical Systems Inc Stock (MMSI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| NEIL W PETERSON | Officer |
Aug 24 '26 |
Proposed Sale |
90.45 |
7,500 |
678,360 |
0 |
| NEIL W PETERSON | Officer |
Aug 04 '26 |
Proposed Sale |
85.00 |
21,449 |
1,823,165 |
0 |
| Peterson Neil W. | CHIEF OPERATING OFFICER |
Aug 04 '26 |
Sale |
85.00 |
21,449 |
1,823,165 |
25,551 |
| Gunderson Thomas J. | Director |
May 20 '26 |
Option Exercise |
52.17 |
21,250 |
1,108,612 |
60,741 |
| Smith Christian Adam | Chief Commercial Officer |
May 11 '26 |
Buy |
61.00 |
1,626 |
99,186 |
2,220 |
| Lloyd Brian G. | CHIEF LEGAL OFFICER, SECRETARY |
May 07 '26 |
Buy |
62.62 |
2,000 |
125,250 |
2,000 |
| LYNNE WARD | Director |
May 07 '26 |
Proposed Sale |
62.61 |
5,000 |
313,036 |
0 |
| Ward Lynne N. | Director |
May 07 '26 |
Sale |
62.61 |
5,000 |
313,035 |
7,809 |
| Aronson Martha Goldberg | President and CEO |
May 06 '26 |
Buy |
60.44 |
2,000 |
120,880 |
49,792 |
| Parra Raul Jr. | CFO AND TREASURER |
May 06 '26 |
Buy |
61.01 |
1,500 |
91,515 |
58,843 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):